Related Experiment Videos
Autoreactive T cells in human type 1 diabetes
Timothy I M Tree1, Mark Peakman
1Department of Immunobiology, Guy's, King's, and St. Thomas' School of Medicine, King's College London, Denmark Hill Campus, London SE5 9NU, UK.
Endocrinology and Metabolism Clinics of North America
|April 1, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacology and nonclinical development of teplizumab, a first-in-class immunotherapy for delaying the onset of type 1 diabetes.
The Journal of pharmacology and experimental therapeutics·2026
Bi-allelic variants in the non-protein-coding minor spliceosome components RNU6ATAC and RNU4ATAC cause syndromic monogenic autoimmune diabetes.
American journal of human genetics·2026
Genetic risk in extremely early onset type 1 diabetes.
medRxiv : the preprint server for health sciences·2025
Adrenal Disorders in Pregnancy.
Endocrinology and metabolism clinics of North America·2026
Diagnosis and Management of Adrenocortical Carcinoma.
Endocrinology and metabolism clinics of North America·2026
Pheochromocytomas and Paragangliomas.
Endocrinology and metabolism clinics of North America·2026
Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.
Endocrinology and metabolism clinics of North America·2026
Primary Bilateral Macronodular Adrenal Hyperplasia.
Endocrinology and metabolism clinics of North America·2026
Evaluation and Management of Primary Aldosteronism.
Endocrinology and metabolism clinics of North America·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026